We analyzed the correlation between RBM10 expression and the Bcl-xS to Bcl-xL ratio in quartiles in a total of 87 EGFR-mutated NSCLC clinical samples, which are included in Supplemental Figure 7A. This evidence concerns the gene BCL2L1 and non-small cell lung carcinoma.